Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% |
|
-.--% | -.--% |
14/06 | Abionyx: positive response from FDA, share price rises | CF |
13/06 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
12TCr | ||||||
12TCr | ||||||
2.7TCr | - | |||||
2.04TCr | - | |||||
1.59TCr | - |